Results 181 to 190 of about 122,296 (281)

Efficacy of Biologics in Aspirin Exacerbated Respiratory Disease

Clinical and Translational Allergy, Volume 16, Issue 10, October 2026.
ABSTRACT Background Aspirin‐exacerbated respiratory disease (AERD), also termed nonsteroidal anti‐inflammatory drug exacerbated respiratory disease (NERD), is characterized by asthma, chronic rhinosinusitis with nasal polyposis, and hypersensitivity to cyclooxygenase‐1 inhibitors, frequently resulting in severe, treatment‐refractory airway disease ...
Jennifer K. Priessnitz, Anastasia Hagopian, Alison J. Patev, Joseph K. Han, Kent K. Lam   +4 more
wiley   +1 more source

Gastric Herpes Zoster [PDF]

BMJ, 1948
openaire   +5 more sources

Three injections of freeze‐dried platelet factor concentrate provide greater clinical response than single injection in the treatment of knee osteoarthritis

Journal of Experimental Orthopaedics, Volume 13, Issue 4, October 2026.
Abstract Purpose Single‐injection freeze‐dried platelet factor concentrate (PFC‐FD) has been shown to be safe and effective in the treatment of early knee osteoarthritis (OA) with clear advantages over other PRP processing methods. No previous clinical investigations have examined multiple PFC‐FD doses.
Tadahiko Ohtsuru, Hiroto Hanai, Taro Akimori, Wataru Ando, Norimasa Nakamura, Stephen Lyman   +5 more
wiley   +1 more source

Reduced Pathogen‐Specific T Cell Response With BCMA‐Targeted T Cell‐Engaging Therapy to Multiple Myeloma

eJHaem, Volume 7, Issue 5, October 2026.
ABSTRACT Introduction Bispecific antibody (BsAb) treatment can lead to increased infections in myeloma patients. Methods We used ELISpot and flow cytometry to test the T cell response to BCMA‐CD3‐bispecific T cell engager (BiTE) pavurutamab (PAV) and BCMA‐expressing myeloma cells after in vitro culture.
Ida Steiro, Synne Stokke Tryggestad, Eli Svorkdal Hess, Hanne Hella, Pegah Abdollahi, Kari Lenita Falck Moore, Margrete Friestad, Magne Børset, Tobias S. Slørdahl, Anne Marit Sponaas   +9 more
wiley   +1 more source

Herpes zoster vaccination in inflammatory bowel disease: Evidence, guidelines, and reality. [PDF]

World J Virol
Manrai M, Pachisia AV, Jha AA, Shukla R, Hande V, Thareja S.   +5 more
europepmc   +1 more source

Mandibular Herpes Zoster

Internal Medicine, 2019
Kosami, Koki, Kenzaka, Tsuneaki
openaire   +3 more sources

Cytomegalovirus in Bronchoalveolar Lavage Fluid: A Predictor of Outcome in Immunocompromised Patients

Journal of Medical Virology, Volume 98, Issue 10, October 2026.
ABSTRACT Cytomegalovirus (CMV) is a prevalent herpesvirus that remains typically asymptomatic in immunocompetent individuals but can cause severe, potentially life‐threatening disease in immunocompromised patients. This study assessed the impact of CMV‐associated lower respiratory tract infections (LRTIs), diagnosed by polymerase chain reaction (PCR ...
Theodora Zouvani, Meropi Karakioulaki, Kathleen Jahn, Sebastian Fähndrich, Björn C. Frye, Leticia Grize, Eleni Papakonstantinou, Hartmut Hengel, Karoline Leuzinger, Hans H. Hirsch, Daiana Stolz   +10 more
wiley   +1 more source

Desquamative gingivitis: A suspected herpes zoster manifestation? [PDF]

J Indian Soc Periodontol
Sharma R, Sangwan A, Singh H.
europepmc   +1 more source

Occurrence of Sensorineural Hearing Loss in Viral Meningitis and Encephalitis

Journal of Medical Virology, Volume 98, Issue 10, October 2026.
ABSTRACT Hearing loss in viral neuroinfections is poorly investigated. The present study aimed to clarify if hearing loss can develop in viral meningitis and encephalitis. An OAE (oto‐acoustic emission) was measured in adult patients with viral meningitis and encephalitis on the day of admission and 30–60 days after discharge.
Elisa Skovgaard Jensen, Andreas Vestergaard Jensen, Per Cayé‐Thomasen, Pelle Trier Petersen, Birgitte Rønde Hansen, Nichlas Hovmand, Rannvá Winther, Jonas Bruun Kjærsgaard, Malene Kirchmann, Christian T. Brandt, DASGIB Study Group, Helene Mens, Birgitte Rønde Hansen, Hans Rudolf Lüttichau, Micha Jepsen, Christian Brandt, Christian Østergaard Andersen, Lykke Larsen, Merete Storgaard, Jacob Bodilsen, Henrik Nielsen   +20 more
wiley   +1 more source

Review article: Immunosuppression in Decompensated Autoimmune Hepatitis Cirrhosis ‐ To Suppress or Not to Suppress?

Alimentary Pharmacology &Therapeutics, Volume 64, Issue 7, Page 897-918, October 2026.
Individualized assessment identifies patients with decompensated autoimmune hepatitis cirrhosis who are likely to benefit from a time‐limited trial of immunosuppression versus those requiring immediate liver transplant evaluation. Early objective response monitoring (bilirubin, MELD‐Na and AST/ALT) guides continuation of immunosuppression, promotes ...
Pedro Robson Costa Passos, Valbert Oliveira Costa Filho, Guilherme Grossi Lopes Cançado   +2 more
wiley   +1 more source